Refine
Year of publication
Document Type
- Article (11)
Has Fulltext
- yes (11)
Is part of the Bibliography
- no (11)
Keywords
- 2-deoxy-D-ribose (1)
- Air traffic (1)
- Artenzusammensetzung (1)
- Attention (1)
- Autism (1)
- Biomarker (1)
- Bottom-up (1)
- Culicidae (1)
- Desinfektion von Flugzeugen (1)
- Disinfection of aircraft (1)
Mit dem Verschwinden der Malaria aus Deutschland in der Mitte des letzten Jahrhunderts sank auch das wissenschaftliche Interesse an Stechmücken. Seit Jahrzehnten sind keine großflächigen systematischen Studien zum Vorkommen und zur Verbreitung der einheimischen Culicidenarten mehr durchgeführt worden, da diese scheinbar keine Vektorfunktion mehr hatten. Lediglich saisonal bedingte Massenvermehrungen waren und sind Anlass zu gezielten Bekämpfungsaktionen, die auch aktuell regionale Daten zur Stechmückenfauna liefern (BECKER & KAISER 1995). Diese und weitere sporadische Studien aus den letzten Jahren (BASTIAN 2000; HERRMANN 2000; KAMPEN unveröffentl.) zeigen, dass potenzielle Malariaüberträger nach wie vor bei uns heimisch sind. Gerade die anhaltende Diskussion über ‚emerging and resurging infectious diseases’ in Verbindung mit möglichen Klima- und Umweltveränderungen (GRATZ 1999, 2004) sollte aber das allgemeine Interesse an den einheimischen (potenziellen) Vektoren wecken, um für Eventualitäten gewappnet zu sein. Der weltweite Massentourismus und Tierhandel sorgt nicht nur für ein permanentes Angebot an Infektionsquellen für einheimische hämatophage Arthropoden, sondern erleichtert auch die Einschleppung und Ausbreitung von allochthonen Vektoren. So gelangte etwa die Tigermücke Aedes albopictus, ein effizienter Gelbfieber- und Dengue-Vektor, zu Beginn der 1990er Jahre mit dem Gebrauchtreifenhandel nach Südeuropa (KNUDSEN et al. 1996) und wandert seitdem ständig weiter nach Norden (SCHAFFNER 2001; FLACIO et al. 2004; SCHOLTE et al. 2006). Doch auch Zugvögel bringen seit jeher Viren aus afrikanischen Ländern nach Europa undkönnen einheimische Vektoren infizieren (MALKINSON & BANET 2002). Bis auf wenige Ausnahmen blieben große Epidemien bisher aus. Nicht so in Nordamerika, wo 1999 auf bislang unbekanntem Wege das West Nil-Virus eingeschleppt wurde und sich bis 2003 über die gesamten Vereinigten Staaten ausbreitete (GOULD & FIKRIG 2004). Zahlreiche Todesfälle bei Menschen, Pferden und Vögeln, insbesondere auf eine Virusübertragung durch Culex pipiens zurückzuführen, waren die Folge. Mit dem Tahyna-, Sindbis- und West Nil-Virus kursieren mindestens drei pathogene Stechmückenassoziierte Viren auch in Europa (ASPÖCK 1996; LUNDSTRÖM 1999). Erst kürzlich wurde in toten Vögeln in Österreich erstmals das Usutu-Virus außerhalb Afrikas nachgewiesen (WEISSENBÖCK et al. 2002). Ob es humanpathogenes Potenzial hat, ist unbekannt. Schließlich sind Stechmücken als Überträger der caninen Filariose von Bedeutung, die gelegentlich auch den Menschen befallen kann und sich offenbar ebenfalls vom Mittelmeerraum nach Norden ausbreitet (MURO 1999; PAMPIGLIONE & RIVASI 2000). Die vorgestellte Studie soll einen Beitrag zur Aktualisierung unserer Kenntnisse zum Vorkommen, zur Verbreitung und zur Biologie einheimischer Culiciden liefern, die erforderlich sind, um auf autochthone Erregerübertragung in geeigneter Weise reagieren zu können.
Die Insekten
(1993)
Die Insektenfauna des Naturraumes Drömling ist sowohl durch die an Wasser und Feuchtgebiete gebundenen hygrophilen Arten als auch durch die an Trockenheit auf den Horsten ("Sandinseln") gebundenen xerophilen Arten gekennzeichnet. Derartige hochspezialisierte Arten sind als typische Repräsentanten ihrer Biotope zur Bioindikation für intakte Lebensräume geeignet. Zwischen beiden "Extremen" leiten die in ihren Ansprüchen wesentlich variableren mesophilen Arten über, die als euryöke Artengruppe weniger zur Charakterisierung der Lebensraumsituation geeignet sind.
Paricalcitol is approved for prevention and therapy of secondary hyperparathyroidism (sHPT) in patients with chronic kidney disease (CKD), with only short-term data in clinical routine settings. A 12-month observational study was conducted in Germany and Austria (90 centers, 761 patients) from 2008 to 2013. Laboratory values, demographical, and clinical data were documented in 629 dialysis patients and 119 predialysis patients. In predialysis patients, median intact parathormone (iPTH) was 180.0 pg/mL (n = 105) at the start of the study, 115.7 pg/mL (n = 105) at last documentation, and 151.8 pg/mL (n = 50) at month 12, with 32.4% of the last documented iPTH values in the KDOQI (Kidney Disease Outcomes Quality Initiative) target range. In dialysis patients, median iPTH was 425.5 pg/mL (n = 569) at study start, 262.3 pg/mL (n = 569) at last documentation, and 266.1 pg/mL (n = 318) at month 12, with 36.5% of dialysis patients in the KDOQI target range. Intravenous paricalcitol showed more homogenous iPTH control than oral treatment. Combined analysis of all dialysis patients indicated comparable and stable mean serum calcium and phosphate levels throughout the study. Clinical symptoms, such as itching, bone pain, and fatigue, were improved compared with study entry. The spectrum and frequency of adverse events mirrored the known pattern for patients on dialysis. Paricalcitol is efficacious and has a consistent safety profile in sHPT over 12 months.
Background: Since 2009, IPF patients across Europe are recruited into the eurIPFreg, providing epidemiological data and biomaterials for translational research.
Methods: The registry data are based on patient and physician baseline and follow-up questionnaires, comprising 1700 parameters. The mid- to long-term objectives of the registry are to provide clues for a better understanding of IPF phenotype sub-clusters, triggering factors and aggravating conditions, regional and environmental characteristics, and of disease behavior and management.
Results: This paper describes baseline data of 525 IPF subjects recruited from 11/2009 until 10/2016. IPF patients had a mean age of 68.1 years, and seeked medical advice due to insidious dyspnea (90.1%), fatigue (69.2%), and dry coughing (53.2%). A surgical lung biopsy was performed in 32% in 2009, but in only 8% of the cases in 2016, possibly due to increased numbers of cryobiopsy. At the time of inclusion in the eurIPFreg, FVC was 68.4% ± 22.6% of predicted value, DLco ranged at 42.1% ± 17.8% of predicted value (mean value ± SD). Signs of pulmonary hypertension were found in 16.8%. Steroids, immunosuppressants and N-Acetylcysteine declined since 2009, and were replaced by antifibrotics, under which patients showed improved survival (p = 0.001).
Conclusions: Our data provide important insights into baseline characteristics, diagnostic and management changes as well as outcome data in European IPF patients over time.
Trial registration: The eurIPFreg and eurIPFbank are listed in ClinicalTrials.gov(NCT02951416).
Autism spectrum disorders (ASD) have been associated with sensory hypersensitivity. A recent study reported visual acuity (VA) in ASD in the region reported for birds of prey. The validity of the results was subsequently doubted. This study examined VA in 34 individuals with ASD, 16 with schizophrenia (SCH), and 26 typically developing (TYP). Participants with ASD did not show higher VA than those with SCH and TYP. There were no substantial correlations of VA with clinical severity in ASD or SCH. This study could not confirm the eagle-eyed acuity hypothesis of ASD, or find evidence for a connection of VA and clinical phenotypes. Research needs to further address the origins and circumstances associated with altered sensory or perceptual processing in ASD.
Enhanced apoptosis and elevated levels of reactive oxygen species (ROS) play a major role in aging. In addition, several neurodegenerative diseases are associated with increased oxidative stress and apoptosis in neuronal tissue. Antioxidative treatment has neuro-protective effects. The aim of the present study was to evaluate changes of susceptibility to apoptotic cell death by oxidative stress in aging and its inhibition by the antioxidant Ginkgo biloba extract EGb761. We investigated basal and ROS-induced levels of apoptotic lymphocytes derived from the spleen in young (3 months) and old (24 months) mice. ROS were induced by 2-deoxy-D-ribose (dRib) that depletes the intracellular pool of reduced glutathione. Lymphocytes from aged mice accumulate apoptotic cells to a significantly higher extent under basal conditions compared to cells from young mice. Treatment with dRib enhanced this difference, implicating a higher sensitivity to ROS in aging. Apoptosis can be reduced in vitro by treatment with EGb761. In addition, mice were treated daily with 100mg/kg EGb761 per os over a period of two weeks. ROS-induced apoptosis was significantly reduced in the EGb761 group. Interestingly, this effect seemed to be more pronounced in old mice.
Autism spectrum disorder and schizophrenia share a substantial number of etiologic and phenotypic characteristics. Still, no direct comparison of both disorders has been performed to identify differences and commonalities in brain structure. In this voxel based morphometry study, 34 patients with autism spectrum disorder, 21 patients with schizophrenia and 26 typically developed control subjects were included to identify global and regional brain volume alterations. No global gray matter or white matter differences were found between groups. In regional data, patients with autism spectrum disorder compared to typically developed control subjects showed smaller gray matter volume in the amygdala, insula, and anterior medial prefrontal cortex. Compared to patients with schizophrenia, patients with autism spectrum disorder displayed smaller gray matter volume in the left insula. Disorder specific positive correlations were found between mentalizing ability and left amygdala volume in autism spectrum disorder, and hallucinatory behavior and insula volume in schizophrenia. Results suggest the involvement of social brain areas in both disorders. Further studies are needed to replicate these findings and to quantify the amount of distinct and overlapping neural correlates in autism spectrum disorder and schizophrenia.
As major sources of reactive oxygen species (ROS), mitochondrial structures are exposed to high concentrations of ROS and may therefore be particularly susceptible to oxidative damage. Mitochondrial damage could play a pivotal role in the cell death decision. A decrease in mitochondrial energy charge and redox state, loss of transmembrane potential (depolarization), mitochondrial respiratory chain impairment, and release of substances such as calcium and cytochrome c all contribute to apoptosis. These mitochondrial abnormalities may constitute a part of the spectrum of chronic oxidative stress in Alzheimer's disease. Accumulation of amyloid beta (Abeta) in form of senile plaques is also thought to play a central role in the pathogenesis of Alzheimer's disease mediated by oxidative stress. In addition, increasing evidence shows that Abeta generates free radicals in vitro, which mediate the toxicity of this peptide. In our study, PC12 cells were used to examine the protective features of EGb 761(definition see editorial) on mitochondria stressed with hydrogen peroxide and antimycin, an inhibitor of complex III. In addition, we investigated the efficacy of EGb 761 in Abeta-induced MTT reduction in PC12 cells. Moreover, we examined the effects of EGb 761 on ROS levels and ROS-induced apoptosis in lymphocytes from aged mice after in vivo administration. Here, we will report that EGb 761 was able to protect mitochondria from the attack of hydrogen peroxide, antimycin and Abeta. Furthermore, EGb 761 reduced ROS levels and ROS-induced apoptosis in lymphocytes from aged mice treated orally with EGb 761 for 2 weeks. Our data further emphasize neuroprotective properties of EGb 761, such as protection against Abeta-toxicity, and antiapoptotic properties, which are probably due to its preventive effects on mitochondria.
Comparative proteomics reveals a diagnostic signature for pulmonary head‐and‐neck cancer metastasis
(2018)
Patients with head‐and‐neck cancer can develop both lung metastasis and primary lung cancer during the course of their disease. Despite the clinical importance of discrimination, reliable diagnostic biomarkers are still lacking. Here, we have characterised a cohort of squamous cell lung (SQCLC) and head‐and‐neck (HNSCC) carcinomas by quantitative proteomics. In a training cohort, we quantified 4,957 proteins in 44 SQCLC and 30 HNSCC tumours. A total of 518 proteins were found to be differentially expressed between SQCLC and HNSCC, and some of these were identified as genetic dependencies in either of the two tumour types. Using supervised machine learning, we inferred a proteomic signature for the classification of squamous cell carcinomas as either SQCLC or HNSCC, with diagnostic accuracies of 90.5% and 86.8% in cross‐ and independent validations, respectively. Furthermore, application of this signature to a cohort of pulmonary squamous cell carcinomas of unknown origin leads to a significant prognostic separation. This study not only provides a diagnostic proteomic signature for classification of secondary lung tumours in HNSCC patients, but also represents a proteomic resource for HNSCC and SQCLC.